Literature DB >> 6075414

The mechanism of action of ceruloplasmin in inhibiting ascorbic acid-induced depolymerization of hyaluronic acid.

W Niedermeier, R P Laney, C Dobson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6075414     DOI： 10.1016/0304-4165(67)90136-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  5 in total

1.  Studies on the structure of hyaluronic acid. Characterization of the product formed when hyaluronic acid is treated with ascorbic acid.

Authors:  D A Swann
Journal:  Biochem J       Date:  1969-10       Impact factor: 3.857

2.  Determination of molecular weight of hyaluronic acid in bovine vitreous humour and Healon by high performance gel permeation chromatography and its depolymerization with ascorbic acid.

Authors:  Z Iqbal; J M Midgley; D G Watson; S D Karditsas; G N Dutton; W Wilson
Journal:  Pharm World Sci       Date:  1997-10

3.  Ascorbic acid deficiency in liver disease.

Authors:  A D Beattie; S Sherlock
Journal:  Gut       Date:  1976-08       Impact factor: 23.059

4.  Effects of copper depletion and D-penicillamine treatment on the ocular inflammatory response.

Authors:  M C McGahan; L N Fleisher; A M Grimes
Journal:  Agents Actions       Date:  1991-11

5.  Protective effects of manganese(II) chloride on hyaluronan degradation by oxidative system ascorbate plus cupric chloride.

Authors:  Katarína Valachová; Grigorij Kogan; Peter Gemeiner; Ladislav Soltés
Journal:  Interdiscip Toxicol       Date:  2010-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.